ADB-BUTINACA acts as an agonist at CB1 and CB2 receptors, mimicking the results of organic cannabinoids. It is commonly used in investigate to check receptor interactions as well as their influence on the central anxious system. The powdered form of ADB-BUTINACA permits specific measurement and m